GSK’s ViiV Healthcare joint venture has announced data backing an injection taken that can suppress the HIV virus even if it is taken only six times a year, instead of every month.
The FDA has approved a new drug to treat certain types of multi-drug resistant tuberculosis – but it’s taken a not-for-profit organisation supported by governments and the billionaire phila
Gilead’s chief scientific officer, John McHutchison is to leave the company at the beginning of next month during a period of change at the big US pharma.
A trial of Roche’s successor to flu medicine Tamiflu has met its goal in a phase 3 trial, with results showing that the new drug Xofluza is well tolerated in children with the flu.